Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | POLA1 | P09884 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19816871 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL8441499 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL8811913 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL8814164 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL7201423 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL436881 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL274488 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL1976573 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL8812283 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL | |
| SCHEMBL3653121 | 1.00 | LMNA (0.68) | LMNAALDH1A1TSHREPHX2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10801046-B2 | Methods and materials for biosynthesizing multifunctional, multivariate molecules via carbon chain modification | INVISTA NORTH AMERICA S.A.R.L. (US) | 2020-10-13 | — | — | US | claimed |
| EP-3488000-A1 | METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION | INVISTA Textiles (U.K.) Limited (GB) | 2019-05-29 | — | — | EP | claimed |
| WO-2018022633-A1 | METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION | INVISTA TEXTILES (U.K.) LIMITED (GB) | 2018-02-01 | — | — | WO | claimed |
| US-20180023103-A1 | METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION | INVISTA NORTH AMERICA S.A.R.L. | 2018-01-25 | — | — | US | claimed |
| US-12486468-B2 | Method for the preparation of omega-amino-carboxylic acids and derivatives thereof | VERSALIS S.P.A. (IT) | 2025-12-02 | — | — | US | disclosed |
| EP-4603483-A1 | PROCESS FOR THE PREPARATION OF TRIOXANE DERIVATIVES | Evonik Oxeno GmbH & Co. KG (DE) | 2025-08-20 | — | — | EP | disclosed |
| EP-4603474-A1 | PROCESS FOR THE PREPARATION OF AN OMEGA-HYDROXYCARBOXYLIC ACID ESTER FROM A TRIOXANE DERIVATIVE | Evonik Oxeno GmbH & Co. KG (DE) | 2025-08-20 | — | — | EP | disclosed |
| US-20250257047-A1 | METHOD FOR PREPARING TRIOXANE DERIVATIVES | EVONIK OXENO GMBH & CO. KG (DE) | 2025-08-14 | — | — | US | disclosed |
| US-20250136887-A1 | METHOD FOR THE PREPARATION OF OMEGA-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | VERSALIS S.P.A. (IT) | 2025-05-01 | — | — | US | disclosed |
| EP-4392401-A1 | METHOD FOR THE PREPARATION OF OMEGA-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | Versalis S.p.A. (IT) | 2024-07-03 | — | — | EP | disclosed |
| CN-117836267-A | Process for preparing omega-aminocarboxylic acids and derivatives thereof | 维尔萨利斯股份公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2023026127-A1 | METHOD FOR THE PREPARATION OF Ω-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | VERSALIS S.P.A. (IT) | 2023-03-02 | — | — | WO | disclosed |
| EP-0446485-A2 | Peptide analogues with renininhibiting activity | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
| EP-0446751-A1 | Glycolic acid derivatives | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
| EP-0418696-A2 | Derivatives of aminoacids | MERCK PATENT GmbH (DE) | 1991-03-27 | — | — | EP | disclosed |
| US-4968794-A | ANTAGONISTS OF PLATELET ACTIVATING FACTOR | BOEHRINGER INGELHEIM KG (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4950666-A | INSECTS, ACARIDS, AND NEMATODES | FMC CORPORATION (US) | 1990-08-21 | — | — | US | disclosed |
| CN-1037155-A | Amino acid derivative | MERCK PATENT GMBH (DE) | 1989-11-15 | — | — | CN | disclosed |
| EP-0339483-A2 | Renin inhbiting amino-acid derivatives | MERCK PATENT GmbH (DE) | 1989-11-02 | — | — | EP | disclosed |
| EP-0337334-A2 | Renin-inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1989-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257047-A1 | METHOD FOR PREPARING TRIOXANE DERIVATIVES | DDX41, DDX42, ALPP | LMNA 322/4885ALDH1A1 4081/4885TSHR 1255/4885 |
| US-12486468-B2 | Method for the preparation of omega-amino-carboxylic acids and derivatives thereof | FADS1, ABHD6, FASN | LMNA 1843/4885ALDH1A1 864/4885TSHR 4010/4885 |
| US-20250136887-A1 | METHOD FOR THE PREPARATION OF OMEGA-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | FADS1, ABHD6, FASN | LMNA 1843/4885ALDH1A1 864/4885TSHR 4010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.